CEO/Chief Nursing Executive
American Organization for Nursing Leadership
Claire Zangerle is the Chief Executive Officer of the American Organization for Nursing Leadership and the American Organization for Nursing Leadership Foundation and is the Chief Nurse Executive of the American Hospital Association.
Most recently she served as Principle of CMZ Strategies, LLC, focused on nurse leader coaching, nursing organization strategy and nursing’s interdependencies with functional disciplines. Formerly she served as Chief Nurse Executive at Allegheny Health Network in Pittsburgh, PA, CEO of the Visiting Nurse Association of Ohio and in various roles at the Cleveland Clinic in Cleveland, OH including Chief Nursing Officer, Director of Quality and Accreditation, and Director of Preventive Cardiology. She began her nursing career at Memorial Hermann Hospital in Houston in Cardiothoracic Surgery and Trauma. As a nursing student, she worked as a nursing assistant at The Methodist Hospital in Houston.
Dr. Zangerle received a Bachelor of Science in Exercise Physiology from Texas A&M University, an Associate Degree of Nursing from Houston Baptist University, a master’s in business administration from Lake Erie College, a master’s in nursing from Kent State University, and a Doctorate in Nursing Practice from Texas Christian University. She is certified as an Advanced Nurse Executive with the American Nurses Credentialing Center, a Fellow of the American Organization for Nursing Leadership and a Fellow of the American Academy of Nursing.
Dr. Zangerle serves as a trustee of AtlantiCare Health System, advisory board member of Biovigil, a public board member of Rasmusen University and a board member of the Cleveland Animal Protective League. She is a former board member of AONL and board of trustee of the American Hospital Association. She was recently named in Modern Healthcare as one of the nation’s 50 Most Influential Clinical Executives.
Hot Topic: Comprehensive Strategies to Address Healthcare Workplace Violence
Tuesday, March 3, 2026
7:30am - 9:00am CT